Carotid Artery Disease in Diabetic Patients

1. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in managed care population. Diabetes Care. 1997; 20: 1396-1402. 1b. Berry J, Keebler Me, McGuire DK. Diabetes Mellitus and Cardiovascular Disease: Pandora's Box has been opened. Herz. 2004; 29(5): 456-62.Search in Google Scholar

2. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of Ischemic Stroke in Patients with Diabetes. The Greater Cincinnati/Northern Kentucky Stroke study. Diabetes care. 2005; 28: 355-359.10.2337/diacare.28.2.355Search in Google Scholar

2b. Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Vermeulen G, Gorter JW, et al. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet. 2005; 365(9477): 2098-104.10.1016/S0140-6736(05)66734-7Search in Google Scholar

3. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hause WA, et al. Race-ethnic disparities in in the impact of stroke risk factors in Northern Manhattan Stroke study. Stroke. 2001; 32: 1732-5. 3b. Mallick U, Dorobantu M, Iqbal B, Cheta D. An evidence based approach to the management of cardiovascular disease in Diabetes mellitus. In Cheta D. Vascular Involvment in Diabetes. Carger, Basel 2005.Search in Google Scholar

4. Yamanouchi H, Shimada H, Kuramoto K. Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital. (Tokyo Metropolitan Geriatric Hospital series) Klin Wochenschr. 1990; 68: 1173-7.10.1007/BF018152732280580Search in Google Scholar

5. Hillen T, Coshal C, Tilling K. on behalf of the South London Stroke register. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcome of stroke recurrence: The South London Stroke Register. Stroke. 2003; 34: 1457-63.10.1161/01.STR.0000072985.24967.7F12750544Search in Google Scholar

6. Kuusisto J, Mykkanene L, Pyorala K, Laakso M. Noninsulin dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994; 25: 1157-64.10.1161/01.STR.25.6.1157Search in Google Scholar

7. Matz K, Jeresztes K, Tatschl C. Disorders if glucose metabolism in acute stroke patients: an unrecognized problem. Diabetes Care. 2006; 29: 792-7.10.2337/diacare.29.04.06.dc05-181816567817Search in Google Scholar

8. Karapanaytoides T, Piechowsky-Jozwiak B, van Melle G. Stroke patterns, ethiology and prognosis in patients with diabetes mellitus. Neurology. 2004; 62: 1558-62.10.1212/01.WNL.0000123252.55688.0515136681Search in Google Scholar

9. Pinto A, Tuttolomondo A, Di Raimondo D, Di Sciacca R, Fernandez P, Di Gati M, et al. A case control study between diabetic and non-diabetic subjects with ischemic stroke. Int J Cardiol. 2008 Apr 25; 125(3):391-6.10.1016/j.ijcard.2007.03.10917490764Search in Google Scholar

10. Shah IM, Ghosh SK, Collier A. Stroke presentation in Type 2 diabetes and the metabolic syndrome. International Angiology. 2007; 26(01): 26-31.Search in Google Scholar

11. Mohave MR, Hashenmazadeh M, Jamal MM. Diabetes mellitus is a strong independent risk factor for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005; 105: 315-8.10.1016/j.ijcard.2005.02.05016274775Search in Google Scholar

12. Fonarow GC, Srikanthan P. Diabetic cardiomyopathy. Endocrinol Metab Clin North Am. 2006; 35: 575-99.10.1016/j.ecl.2006.05.00316959587Search in Google Scholar

13. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476-84.10.1016/S0002-9343(99)80348-9Search in Google Scholar

14. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271: 840-44.10.1001/jama.1994.03510350050036Search in Google Scholar

15. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small vessel disease: an autopsy study. Stroke. 1997; 28: 2222-9.10.1161/01.STR.28.11.22229368569Search in Google Scholar

16. Arauz A, Murrillo L, Cantu C. Prospective study of single and multiple lacunar infarct using magnetic resonance imaging: risk factors, recurrence and outcome in 175 consecutive cases. Stroke. 2003; 34: 2453-8.10.1161/01.STR.0000090351.41662.9114500936Search in Google Scholar

17. Rajala U, Laakso M, Painvansalo M. Blood pressure and atherosclerotic plaques in carotid, aortic and femoral arteries in elderly Finns with diabetes mellitus and impaired glucose tolerance. J Hum Hypertension. 2005; 19: 85-91.10.1038/sj.jhh.100177915343356Search in Google Scholar

18. Henefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurtschiev T. Postchallenge hyperglycemia relates more strongly than fasting hyperglycemia with carotid intima-media thickness: the RIAD study Diabetic Med. 2000; 17: 835-40.Search in Google Scholar

19. Hancu N, Cerghizam A. Global approach to Cardiovascular Risk in Type 2 Diabetic Persons. In: Hancu N. Cardiovascular Risk in Type 2 Diabetes mellitus. Springer Verlag Berlin, Heidelberg, New York. 2003: 240-76. 19b. Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B. Prevalence of diabetes mellitus and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care. 2006; 29: 363-7.10.2337/diacare.29.02.06.dc05-122916443888Search in Google Scholar

20. 1 IRAS, 2 Kieschl S, Willeit J, for Bruneck Study Group. The natural course of atherosclerosis, part 1: incidence and progression. Arteriosc Thromb Vasc Biol. 1999; 34: 1484-90.Search in Google Scholar

21. Selvin E, Coresh J, Golden SH. Glycemic control, Atherosclerosis, and Risk factors for cardiovascular Disease in Type 2 Diabetes. The Atherosclerosis Risk in Comunities Study. Diabetes Care. 2005; 28: 1963-75.Search in Google Scholar

22. Göksan B, Erkol G, Bozluolcay M, Ince B. Diabetes as a determinant of high-grade carotid artery stenosis: Evaluation of 1,058 cases by Doppler sonography. J Stroke Cerebrovasc Dis. 2001; 10(6): 252-6.10.1053/jscd.2001.12377317903835Search in Google Scholar

23. Yang B, Li TD, Wang JS, Zhi G, Jin WS, Xu Y. Insulin resistance and carotid atherosclerosis in 221 patients with potentional hyperglycemia. Chin Med Sci. 2005; 20(2): 108-11.Search in Google Scholar

24. Baldassarre D, de Jong A, Amato M, Werba PJ, Castelnuovo S, Frigerio B, et al. Carotid intima-media thickness and markers of inflammation endothelial damage and hemostasis. Ann Med. 2007; 1-24.10.1080/0785389070164539917934910Search in Google Scholar

25. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Ca antagonist and ACE reduce IMT. Stroke. 2006 Jul; 37(7): 1933-40.10.1161/01.STR.0000227223.90239.1316763185Search in Google Scholar

26. Williams R, Aiery M. Epidemiology and pathogenesis of diabetic angiopathy. In: Tooke J. Diabetic angiopathy. Arnold 1999.Search in Google Scholar

27. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults. JAMA 2002; 287: 356-9.10.1001/jama.287.3.35611790215Search in Google Scholar

28. Pollex R, Al-Shalli KZ, House AA. Relationship of metabolic syndrome to carotid ultrasound traits. Cardiovascular Ultrasound. 2006; 4: 28-35.10.1186/1476-7120-4-28153386516827932Search in Google Scholar

29. Lu W, Resnick HE, Jablonski KA, et al. Non-HDL Cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care. 2003; 26: 16-23.10.2337/diacare.26.1.1612502653Search in Google Scholar

30. Jiang R, Schulze M, Li Tricia, et al. Non-HDL Cholesterol and Apoplipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes. Diabetes Care; 2004: 27: 1991-7.10.2337/diacare.27.8.199115277429Search in Google Scholar

31. De Vries R, Perton GF, Dallinga-Thie GM. Plasma cholesterol ester transfer is a determinant of intimamedia thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes. 2005; 54(12): 3554-9.10.2337/diabetes.54.12.355416306375Search in Google Scholar

32. Kawamoto R, Tomita H, Oka Y, Kodama A, Kamitami A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med. 2005; 44(12): 1232-8.10.2169/internalmedicine.44.123216415542Search in Google Scholar

33. Hulthe J, Bokemartk L, Wikstrand J, et al. The metabolic syndrome, LDL particle size, and atherosclerosis: The AIR study. Arterioscler Thromb Vasc Biol. 2000; 20: 2140-7.10.1161/01.ATV.20.9.2140Search in Google Scholar

34. Rajala U, Laakso M, Paivansalo M. Low insulin sensitivity measured by both quantitative insulin sensitive check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab. 2002; 87: 5092-7.10.1210/jc.2002-02070312414877Search in Google Scholar

35. Szernichow S, Bertrais S, Oppert JM, Galan P, Blacher J, Ducimetiere P, et al. Body composition and after repartition in relation to structure and function of a large arteries in middle-aged adults (the SU.VI.MAX study). Int J Obes. 2005; 29: 826-32.Search in Google Scholar

36. Nomura M, Kasamai R, Ohashi M, Ymada Y, Abe. H. Significantly higher invcidence of carotid atheroscelrotiss found in japanese type 2 diabetic patients with early nephropathy. Diabetes Res Clin Pract. 2004; 66(1): 161-3.10.1016/j.diabres.2003.09.01415563969Search in Google Scholar

37. Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, et al. Association between carotid artery intimamedia thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007; 49(6): 786-92.10.1053/j.ajkd.2007.03.01117533021Search in Google Scholar

38. Tuimlehto J, Rastenyete D, Jousilahti P, Sarti C, Vartianinen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middleaged Finnish population. Stroke. 1996; 27: 210-5.10.1161/01.STR.27.2.2108571411Search in Google Scholar

39. Folsom AR, Rasmunssen ML, Chambles ME. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ishaemic stroke. ARIC study. Diabetes Care. 1999; 22: 1077-83.10.2337/diacare.22.7.1077Search in Google Scholar

40. Megherbi SA, Mialn C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from from the European BIOMED Stroke project. Stroke. 2003; 344: 688-94.10.1161/01.STR.0000057975.15221.40Search in Google Scholar

41. Bonora E, Kiechl E, Oberhollenzer F. Imparied glucose tolerance, Type 2 diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000; 43: 156-64.10.1007/s001250050024Search in Google Scholar

42. Grag R, Chaudhuri A, Munscauer F. Hyperglycemia insulin and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 20006; 37: 267-73.10.1161/01.STR.0000195175.29487.30Search in Google Scholar

43. Selvin E, Coresh J, Golden SH. Glycemic control, Atherosclerosis, and Risk factors for cardiovascular Disease in Type 2 Diabetes. The Atherosclerosis Risk in Communities.Search in Google Scholar

44. Jorgensen H, Nkayama H, Raaschou HO, Olsen TS, Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994; 25: 1977-84.10.1161/01.STR.25.10.1977Search in Google Scholar

45. Lithner F, Asplund K, Eriksson S, Haag E, Strand T, Wester PO. Clinical characteristics on diabetic stroke patients. Diab Metab. 1988; 14: 15-19.Search in Google Scholar

46. Toni D, Sacchetii Ml, Argentino C, Gentile M, Cavalleti C, Frontoni M, et al. Does hyperglycemia play a role on the outcome of ishemic stroke patients? J Neurol. 1992; 239: 382-6.Search in Google Scholar

47. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al. Stroke topography and outcome in relation to hyperglicaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992; 55: 263-70.10.1136/jnnp.55.4.263Search in Google Scholar

48. Pulsinelli WA, Levy DE, Sigsvee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglicaemia with or without established diabetes mellitus. Am J Med. 1983; 74: 540-4.10.1016/0002-9343(83)91007-0Search in Google Scholar

49. Peila R, Rodriquez BL, Launer LI. Type 2 diabetes, APOE Gene, and the risk for Dementia and related pathologies. Honolulu Asia-Aging study. Diabetes. 2002; 52: 1256-62.10.2337/diabetes.51.4.125611916953Search in Google Scholar

50. Korf ESC, White LR, Scheltens P, Launer LJ. Brain Aging in Very old men with type 2 diabetes. Diabetes Care. 2006; 29(10): 2268-74.10.2337/dc06-024317003305Search in Google Scholar

51. Albers GW, Dalen JE, Laupacis A. Antithrombotic therapy in atrial fibrillation. Chest. 2001; 119; 1945- 2065.10.1378/chest.119.1_suppl.194SSearch in Google Scholar

52. Fuster V, Ryden LE, Asinger RW, Cannon DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2006; 27: 1979-2030.Search in Google Scholar

53. Gage BF, Waterman AD, Shannon W. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285: 2864-70.10.1001/jama.285.22.2864Search in Google Scholar

54. Wang TJ, Massaro JM, Levy D. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003; 290: 1049-1056.10.1001/jama.290.8.1049Search in Google Scholar

55. Adler A, Stratton I, Neil H. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321: 17: 412-9.10.1136/bmj.321.7258.412Search in Google Scholar

56. Chalmers J, Joshi R, Patel A. Advances in reducing the burden of vascular disease in type 2 diabetes. Clin Exp Pharmacol Physiol. 2008 Apr; 35(4): 434-7.10.1111/j.1440-1681.2008.04892.xSearch in Google Scholar

57. Tuomilehto J, Rastenyte D, Birkenhager WH. Effects of calcium-channel blockade on older patients with diabetes and systolic hypertension. (Syst-Eur). N Engl J Med. 1999; 340: 677-84.10.1056/NEJM199903043400902Search in Google Scholar

58. Soucek M. Diabetes Mellitus cerebrovascular disease. Vnitr Lek. 2003 Dec; 49(12): 916-20Search in Google Scholar

59. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology and of the European Association of the Study of Diabetes. doi.10.1093/eurheartj/ehl261.Search in Google Scholar

60. Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2008; 24(6): 465-75.10.1016/S0828-282X(08)70620-2Search in Google Scholar

61. Kawamura T. Cerebrovascular disease and diabetic patients with hypertension. Nippon Rinsho. 2003 Jul; 61(7): 1175-80.Search in Google Scholar

62. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med. 2004; 164: 2106-10.10.1001/archinte.164.19.2106Search in Google Scholar

63. Bosevski M, Georgievska Lj, Borozanov V. Dual antithrombotic therapy and hypercoagulability in diabetic patients. Am Heart J. 2008; 155(6): e47.10.1016/j.ahj.2008.03.001Search in Google Scholar

64. Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Am Heart J. 2008 Jan; 155(1): 93.e1-7.10.1016/j.ahj.2007.10.006Search in Google Scholar

65. Williams LS, Rotich J, Qi R, Fineberg N, Espay N, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 200259; 67-71 x 68. UKPDS 33. Lancet. 1998; 352: 837-53.Search in Google Scholar

66. Diabetes Prevention Research Programme. reduction in the incidence of type 2 diabetes with lifestyle modification and or metformin. N Engl J Med. 2002; 346: 394-46.Search in Google Scholar

67. Heart protection study Collaboration Group. MRC/BHF Heart Protection Study of cholesterollowering in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet. 2003; 361: 2005-16. 67b. Chambers BR, Roberts NG. Asymptomatic carotid artery stenosis. Current Treatment in Cardiovascular Medicine. 2007; 9(2): 81-89.10.1016/S0140-6736(03)13636-7Search in Google Scholar

68. Eton D. Surgery and Medical Management of Cerebrovascular Disease in: Eton D. Vascular Disease: A Multi-Specialty approach to Diagnosis and Management, Landes Bioscience, Austin 1999.Search in Google Scholar

69. Reina-Gutierrez T, Serrano-Hernanado FJ, Sanchez- Hervas L. Recurrent carotid artery stenosis following up endarterectomy: natural history and risk factors. Euro J Vasc Endovasc Surg. 2005; 29(4): 334-41.10.1016/j.ejvs.2004.10.00715749031Search in Google Scholar

70. Tropeano AI, Boutouyrie P, Katsahian S. Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia. J Hypertension. 2004; 22(11): 2153-60.10.1097/00004872-200411000-0001815480100Search in Google Scholar

71. Levy EI, Mocco J, Samuelson RM, Ecker RD, Jahromi BS, Hopkins N. Optimal treatment of carotid artery disease. JACC 2008; 51(10): 979-985.10.1016/j.jacc.2007.10.05218325435Search in Google Scholar

72. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Sys Rev. 2005; 2: CD001923.10.1002/14651858.CD001923.pub2666925716235289Search in Google Scholar

73. Coward Lj, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke. 2005; 36: 905-11.10.1161/01.STR.0000158921.51037.6415746454Search in Google Scholar

74. Hancu N, Cerghizan, Cornelia B. Practical approach to the multifactorial risk in type 2 diabetes. In Cheta D. Multivacsular involvement in Diabetes. Karger, Basel 2005.Search in Google Scholar

75. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR, on behalf of the UKPDS Group. The UKPDS risk engine: a model for the risk the coronary heart disease in type 2 diabetes (UKPDS 56). Clinical Science. 2001; 101: 671-9.10.1042/CS20000335Search in Google Scholar

76. Kothari V, Stevens RJ, Adler AJ, Stratton IM, Manley SE, Neil A, Holman RR, for the UKPDS Group (UKPDS 60) Risk for stroke in the 2 diabetes estimated by UKPDS risk engine. Stroke. 2002; 33: 776-1781.Search in Google Scholar

77. Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabetic Medicine. 2003; 21: 238-245.Search in Google Scholar

79. Haffner SM, Lehot S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-34.10.1056/NEJM1998072333904049673301Search in Google Scholar

80. Doney A, Lee S, Leese G, Morris A, Palmer C. Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With Glutathione S Transferase Theta-Null Genotype (A Go-DARTS Study). Circulation. 2005; 111: 677-88.10.1161/CIRCULATIONAHA.104.50922415927971Search in Google Scholar

81. Morrish NJ, Steven LK, Head J, et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) Diabetologia. 1990, 33: 542-8.10.1007/BF004041422253831Search in Google Scholar

82. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291(3): 335-42.10.1001/jama.291.3.33514734596Search in Google Scholar

83. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association Diabetes Care. 1993 Aug; 16(8): 1199-209.10.2337/diacare.16.8.1199Search in Google Scholar

84. De Angelis M, Scrucca L, Leandri M, et al. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003 Feb; 16(1): 48-55. 84b. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambeaud F, Laskar M. Type 2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vascular Medicine. 2006; 11: 93-99.10.1191/1358863x06vm677oaSearch in Google Scholar

85. Lorenz MW, Markus HS, Bots MI, et al. prediction of Clinical Cardiovascular Events with Carotid Intima- Media Thickness. Circulation. 2007; 115: 459- 467.10.1161/CIRCULATIONAHA.106.628875Search in Google Scholar

86. Duval M, Altman JJ. When should ultrasonography be used to detect asymptomatic carotid atheroma in diabetic patients? Diabetes Metab. 2006 Dec; 32(6): 638-42. 86b. Bosevski M, Borozanov V, Vavlukis M, Pemovska G, Georgievska-Ismail Lj. Carotid ultrasound, blood lipids and waist determination can predict a future coronary revascularisation in the type 2 diabetic cohort. Prilozi. 2007; 28(2): 127-36.Search in Google Scholar

87. Bernard S, Serusclar A, Targe F, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005; 28(5): 1158-9.10.2337/diacare.28.5.1158Search in Google Scholar

88. Parikh A, Daneman D. Is Carotid Ultrasound a Useful Tool in Assessing Cardiovascular Disease in Individuals with Diabetes? Diabetes Technology & Therapeutics. 2004; 6(1): 65-9.10.1089/152091504322783440Search in Google Scholar

89. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke. 2006; 37(9): 2420-7.10.1161/01.STR.0000236632.58323.cdSearch in Google Scholar

90. Bots ML, Evans GW, Riley WA, Grobbe DE. Carotid intima-media thickness Measurements in Intervention studies. Stroke. 2003; 34: 2985-94.10.1161/01.STR.0000102044.27905.B5Search in Google Scholar

91. Spence JD. Ultrasound measurements of carotid plaques as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002; 89 (suppl): 10B-16B.10.1016/S0002-9149(01)02327-XSearch in Google Scholar

92. Giral P, Brucket E, Daiorrou F. Usefulness in predictting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999; 84: 14-17.10.1016/S0002-9149(99)00184-8Search in Google Scholar

93. Lee EJ, Kim HJ, Bae JM, et al. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol. 2007; 28(5): 916-9.Search in Google Scholar

94. Giral P, Brucket E, Daiorrou F. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999; 84: 14-17.10.1016/S0002-9149(99)00184-8Search in Google Scholar

95. Lorenz M, Markus H, Bots M, Rosval M, Sitzer M. Prediction of Clinical Cardiovascular Events with Carotid Intima-media thickness: A systematic review and Meta-analysis. Circulation. 2007; 115: 459-67. 95b. De Angelis M, Strucca L, Leandri M. Prevalence of carotis stenosis in type 2 diabetic pts asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003; 16: 48-55.Search in Google Scholar

96. Bosevski M, Influence of metabolic risk factors for presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease. Diab Vasc Dis Res. 2007; 4(1): 49-52.10.3132/dvdr.2007.00617469044Search in Google Scholar

97. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambeaud F, Laskar M. Type-2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vasc Med. 2006; 11(2): 93-9.10.1191/1358863x06vm677oa16886839Search in Google Scholar

98. Parikh A, Daneman D. Is Carotid Ultrasound a Useful Tool in Assessing Cardiovascular Disease in Individuals with Diabetes? Diabetes Technology & Therapeutics. 2004; 6(1): 65-9.10.1089/15209150432278344015000773Search in Google Scholar

99. Bosevski M, Peovska I, Georgievska-Ismail L. Noninvasive imaging of diabetic vascular disease. Review in Cardiovascular Medicine 2008; Fall (in press)Search in Google Scholar

100. Ragi P, Bellasi A, Ratti C. Ischemia Imaging and Plaque Imaging in Diabetes. Diabetes Care. 28: 2787-2794, 2005.10.2337/diacare.28.11.278716249559Search in Google Scholar

101. Charvat J, Michalova K, Chlumsky J, Horácková M, Valenta Z, Zdárska D. The significance of carotid artery plaques in the detection of coronary artery disease in asymptomatic type 2 diabetic patients. J Int Med Res. 2006; 34(1): 13-20.10.1177/14732300060340010216604819Search in Google Scholar

102. Mudríková T, Szabová E, Tkác I. Carotid intimamedia thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr. 2000; 112(20): 887-91.Search in Google Scholar

103. Bernard S, Sérusclat A, Targe F, Charrière S, Roth O, Beaune J, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005; 28(5): 1158-62.10.2337/diacare.28.5.115815855582Search in Google Scholar

104. Kitagawa K, Hougaku H, Yamagami H, Hashimoto H, Itoh T, Shimizu Y, et al., for OSACA2 Study Group. Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study). Cerebrovasc Dis. 2007; 24(1): 35-42.10.1159/00010311417519542Search in Google Scholar

105. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systemic review. Diabetic Medicine. 2005; 23: 609-616.10.1111/j.1464-5491.2005.01725.x16759301Search in Google Scholar

106. Hodis HM, Mack WJ, LaBree L, Seizer RH, Liu CH, Azen SR. The role of carotid intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998; 128: 262-9.10.7326/0003-4819-128-4-199802150-000029471928Search in Google Scholar

107. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, et al. Carotid Intima- Media thickness in Japanese Type 2 Diabetic Subjects. Predictors of progression and relationship with incident coronary heart disease. Diabetes Care. 2000; 23(9): 1310-5.10.2337/diacare.23.9.131010977024Search in Google Scholar

108. Salonen R, Nyyssonen K, Porkkala E. Kuopio Atherocslerosis Prevention Study (KAPS). A population- based primary preventive trial of the effect of LDL lowering in atherosclerotic progression in carotid and femoral arteries. Circulation. 1995; 92: 1758- 64.10.1161/01.CIR.92.7.1758Search in Google Scholar

109. Chambless LE, Folsom AR, Davis V, Sharett R, Heiss C, Sortlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1979-1998. Am J Epidemiol. 2002; 155: 38-47.10.1093/aje/155.1.3811772783Search in Google Scholar

110. Zuriek M, Touboul PJ, Bonithon-Kopp C, Courbon D, Berr C, Leroux C, Ducimetiere P. Cross sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intimae-media thickness in a general population. The EVA study. Stroke. 2002; 33: 550-5.Search in Google Scholar

111. Mackinnon AD, Jerrard Dune P, Sitzer M, Biehler A, von Kegler S, Markus HS. Rates and determinants of site-specific progression of carotid intima-media thickness: the carotid atherosclerosis progression study (CAPS). Stroke. 2004; 35: 2150-4.10.1161/01.STR.0000136720.21095.f315243147Search in Google Scholar

112. Go AS, Hylek EM, Phillips KA, Chang Y, Henaulst LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-75.10.1001/jama.285.18.237011343485Search in Google Scholar

113. AF Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from the randomized controlled trials. Arch Intern Med. 1994; 154: 1449-57.10.1001/archinte.1994.00420130036007Search in Google Scholar

114. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu- Asia Aging Study. Diabetes. 2006; 29(10): 2268-74.Search in Google Scholar

115. Girdia Cb, Avogaro A, Maggini M, Lombardo F, Mannuci E, Turco S, et al. Incidence and risk factors for stroke in type 2 diabetes. Stroke. 2007; 38: 1154- 60.10.1161/01.STR.0000260100.71665.2f17332448Search in Google Scholar

116. Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens. 2002; 20(9): 1743-51.10.1097/00004872-200209000-0001712195114Search in Google Scholar

117. Hendbald B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intiamedia thickness and stenosis in non-diabetic subjects. Results from a cross sectional study in Malmo. Sweden. Diabet Med. 2000; 17: 299-307.Search in Google Scholar

118. Brohall G, Oden A, Fagberg B. Carotid artery intima- media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabetic Medicine. 2005; 23: 609-16. 118b. Najjar, SS, Scuteri A, Lakatta EG. Arterial aging. Is it an immutable ardiovascular risk factor? Hypertension. 2005; 46: 454-462.Search in Google Scholar

119. Zunker P, Sxhick A, Buschmann HC, Georgiadis D, Nabavi D, Edelmann M, et al. Hyperinsulinism and cerebral microangiopathy. Stroke. 1996; 27: 219-23.10.1161/01.STR.27.2.219Search in Google Scholar

120. Mast H, Thompson JL, Lee Sh, Mohr JR, Sacco RL. Hypertension and diabetes mellitus as determinants for multiple lacunar infarcts. Stroke. 1995; 26: 30-3.10.1161/01.STR.26.1.307839393Search in Google Scholar